Technology | Sudden Cardiac Arrest | December 22, 2015

FDA Approved Pediatric Indication for Zoll's LifeVest Wearable Cardioverter Defibrillator

zoll lifevest

December 22, 2015 - The U.S. Food and Drug Administration has cleared the Zoll LifeVest Wearable Cardioverter Defibrillator, Models 3000, 3100, and 4000, for the additional indication treating pediatric patients 

The Zoll LifeVest is a wearable cardioverter defibrillator to monitor and treat dangerous, abnormally fast heart rhythms. These life threatening arrhythmias can lead to a complete absence of heartbeat (sudden cardiac arrest) and death (sudden cardiac death) if they are not treated. This device was first approved for patients 18 years of age and over in 2001, and it is now available for children. Patients under the age of 18 must have a chest circumference of 26 inches and weigh at least 18.75 kg (approximately 43 pounds, the average size of an 8-year-old).

The LifeVest system consists of two main components, an electrode belt that fits within a lightweight garment worn on the patient's chest, and a monitor and alarm that the patient wears around the waist. The system continuously monitors a patient's heartbeat. If it detects an abnormally fast heartbeat (ventricular tachycardia), or if the system detects an abnormally irregular heartbeat (ventricular fibrillation), it delivers a high-energy shock. 

When the device detects an abnormal heart rhythm, an alarm sequence begins, giving a patient time to stop the treatment if it is not necessary. The patient can prevent a shock by simultaneously pressing two response buttons. If the patient does not respond to the alarm or releases the response buttons, the device continues to alarm and gives a verbal warning that a treatment shock is about to be delivered. Just before a shock is delivered, blue gel within the electrodes is released so the shock will be given efficiently.

For more information: http://lifevest.zoll.com/

Related Content

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

Bystanders using a Philips HeartStart AED for a patient in sudden cardiac arrest.

News | Defibrillator Monitors | June 23, 2020
June 23, 2020 — Philips announced the U.S.
The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and shipping of external defibrillator AEDs in the United States. 
News | Defibrillator Monitors | April 24, 2020
April 24, 2020 — The U.S.
tryker is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.

tryker is launching a voluntary field action on specific units of the LifePAK 15 defibrillator/monitors. The vendor said an issue has been identified where the devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed.

News | Defibrillator Monitors | January 13, 2020
January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 ...
Philips Receives FDA PMA for HeartStart OnSite and HeartStart Home Defibrillators

The Philips HeartStart OnSite automated external defibrillator. Image courtesy of Philips Healthcare.

Technology | Defibrillator Monitors | June 19, 2019
Philips announced the U.S. Food and Drug Administration (FDA) has approved the company’s premarket approval (PMA)...
HeartHero Personal Automated External Defibrillator Wins ACC.19 Innovation Challenge
News | Defibrillator Monitors | April 05, 2019
April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the...
Stryker has recalled its LifePak 15 defibrillator-monitor system because it may lock up after delivering a shock to a patient. The defibrillator was originally made by Physio-Control, before being purchased by Stryker.

Stryker has initiated a field action to prevent its LifePak 15 defibrillator-monitor systems from locking up after delivering a shock to a patient. 

Feature | Defibrillator Monitors | February 04, 2019
February 4, 2019 — Stryker announced Feb.
The Zoll LifeVest wearable defibrillator was the subject of the VEST Trial

The Zoll LifeVest wearable defibrillator system was evaluated in the late-breaking VEST Trial presented at ACC 2018 earlier this year.

Feature | Defibrillator Monitors | July 10, 2018 | Michael J. Mirro, M.D.
Following the...
Rice University Students Improve AED Operation With Needle Pad

The automated external defibrillator add-on developed by Rice University students is a pad of needles that break through the skin's natural impedance barrier to deliver an electric shock to the heart of a patient in cardiac arrest. (Credit: Jeff Fitlow/Rice University)

News | Defibrillator Monitors | April 16, 2018
The skin presents a formidable barrier to life-saving defibrillators, but a team of students from Rice University...
Zoll Canada Equipping Province of Québec Paramedic Services with X Series Monitor/Defibrillators
News | Defibrillator Monitors | October 16, 2017
October 16, 2017 — Zoll Canada, a subsidiary of Zoll Medical Corp., announced it has won the tender to equip all ambu